Published in Arch Intern Med on June 10, 2002
Risk Factors for Venous Thromboembolism in the Community | NCT00011180
British Thoracic Society guidelines for the management of suspected acute pulmonary embolism. Thorax (2003) 5.83
The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol (2008) 3.50
Venous thromboembolism in the outpatient setting. Arch Intern Med (2007) 2.46
Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis. PLoS Med (2012) 1.60
Factors that predict thrombosis in relatives of patients with venous thromboembolism. Blood (2014) 1.45
Fatal pulmonary embolism in hospitalised patients: a necropsy review. J Clin Pathol (2004) 1.44
Noncardiac vascular disease in rheumatoid arthritis: increase in venous thromboembolic events? Arthritis Rheum (2012) 1.34
New insights into the mechanisms of venous thrombosis. J Clin Invest (2012) 1.32
Designing and implementing effective venous thromboembolism prevention protocols: lessons from collaborative efforts. J Thromb Thrombolysis (2010) 1.26
Practical recommendations on the use of lenalidomide in the management of myelodysplastic syndromes. Ann Hematol (2008) 1.20
Correlates and consequences of venous thromboembolism: The Iowa Women's Health Study. Am J Public Health (2009) 1.18
Venous thromboembolism and prognosis in cancer. Thromb Res (2010) 1.16
Epidemiology of cancer-related venous thromboembolism. Best Pract Res Clin Haematol (2009) 1.11
New insights into cancer-associated thrombosis. Arterioscler Thromb Vasc Biol (2009) 1.11
Upper extremity deep vein thrombosis: a community-based perspective. Am J Med (2007) 1.11
Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls. Eur J Epidemiol (2013) 1.09
Epidemiology of venous thromboembolism. Nat Rev Cardiol (2015) 1.07
Lipid biomarkers, hormone therapy and the risk of venous thromboembolism in women. J Thromb Haemost (2009) 1.05
The epidemiology of venous thromboembolism. J Thromb Thrombolysis (2016) 1.00
Korean guidelines for the prevention of venous thromboembolism. J Korean Med Sci (2010) 0.99
Predictors of venous thromboembolism in patients with advanced common solid cancers. J Cancer Epidemiol (2010) 0.98
Venous thromboembolism in medical inpatients--the silent epidemic of neglect. J R Soc Med (2005) 0.97
Snoring and the risk of obstructive sleep apnea in patients with pulmonary embolism. Sleep (2010) 0.96
Incidental pulmonary embolism in cancer patients: clinical characteristics and outcome--a comprehensive cancer center experience. Vasc Health Risk Manag (2011) 0.95
Risk of site-specific cancer in incident venous thromboembolism: a population-based study. Thromb Res (2014) 0.94
Venous thromboembolic disease. J Natl Compr Canc Netw (2011) 0.93
Should we regionalize the management of pulmonary embolism? CMAJ (2008) 0.91
Thromboprophylaxis with low-molecular-weight heparin in medical patients with cancer. Cancer (2009) 0.90
Diagnosing pulmonary embolism. Postgrad Med J (2004) 0.88
Thrombosis and cancer. Nat Rev Clin Oncol (2012) 0.88
Venous thromboembolism (VTE) rates following the implementation of extended duration prophylaxis for patients undergoing surgery for gynecologic malignancies. Gynecol Oncol (2012) 0.88
Venous thromboembolism risk in patients with cancer receiving chemotherapy: a real-world analysis. Oncologist (2013) 0.87
Risk of venous thromboembolism in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) (2013) 0.87
Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patients: MAGELLAN study protocol. J Thromb Thrombolysis (2011) 0.86
Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients. Vasc Health Risk Manag (2007) 0.86
National Trends in Pulmonary Embolism Hospitalization Rates and Outcomes for Adults Aged ≥65 Years in the United States (1999 to 2010). Am J Cardiol (2015) 0.86
Guidelines for deep venous thrombosis prophylaxis during laparoscopic surgery. Surg Endosc (2007) 0.85
Prevention of venous thromboembolism in hospitalized patients with cancer. J Clin Oncol (2009) 0.85
Deep vein thrombosis and pulmonary embolism in hospitalized patients with cirrhosis: a nationwide analysis. Dig Dis Sci (2011) 0.85
ExPeKT--Exploring prevention and knowledge of venous thromboembolism: a two-stage, mixed-method study protocol. BMJ Open (2013) 0.84
Strategies to enhance venous thromboprophylaxis in hospitalized medical patients (SENTRY): a pilot cluster randomized trial. Implement Sci (2013) 0.84
Early venous thromboembolic events are associated with worse prognosis in patients with lung cancer. Lung Cancer (2014) 0.84
Association between the metabolic syndrome, its individual components, and unprovoked venous thromboembolism: results of a patient-level meta-analysis. Arterioscler Thromb Vasc Biol (2014) 0.84
Direct medical costs attributable to venous thromboembolism among persons hospitalized for major operation: a population-based longitudinal study. Surgery (2015) 0.83
Inferior vena cava filters in cancer patients: to filter or not to filter. Ther Clin Risk Manag (2011) 0.83
Incidence of Deep Vein Thrombosis in Hospitalized Chinese Medical Patients and the Impact of DVT Prophylaxis. Thrombosis (2011) 0.83
Prevention of venous thromboembolism in medical patients and outpatients. Nat Rev Cardiol (2009) 0.82
Primary Nephrotic Syndrome in Adults as a Risk Factor for Pulmonary Embolism: An Up-to-Date Review of the Literature. Int J Nephrol (2014) 0.82
The great deception: tranexamic acid and extensive pulmonary emboli. BMJ Case Rep (2013) 0.82
Misdiagnosis of soft tissue sarcomas of the lower limb associated with deep venous thrombosis: report of two cases and review of the literature. BMC Musculoskelet Disord (2013) 0.82
Review of the cost of venous thromboembolism. Clinicoecon Outcomes Res (2015) 0.81
Is thrombophilia a major risk factor for deep vein thrombosis of the lower extremities among Lebanese patients? Vasc Health Risk Manag (2009) 0.81
Venous thromboembolism in nursing home residents: role of selected risk factors. J Am Geriatr Soc (2012) 0.80
Cancer-associated thrombosis. Open Cardiovasc Med J (2010) 0.80
Venous and arterial thrombotic risks with thalidomide: evidence and practical guidance. Ther Adv Drug Saf (2012) 0.80
Differentiation of parenteral anticoagulants in the prevention and treatment of venous thromboembolism. Thromb J (2011) 0.80
Thrombosis, cancer and renal insufficiency: low molecular weight heparin at the crossroads. Support Care Cancer (2012) 0.80
Costs of venous thromboembolism associated with hospitalization for medical illness. Am J Manag Care (2015) 0.80
Antithrombotics in heart failure. Croat Med J (2014) 0.80
Risk factors for venous thromboembolism after acute trauma: A population-based case-cohort study. Thromb Res (2016) 0.79
Fondaparinux vs warfarin for the treatment of unsuspected pulmonary embolism in cancer patients. Drug Des Devel Ther (2016) 0.79
Jobs encompassing prolonged sitting in cramped positions and risk of venous thromboembolism: cohort study. JRSM Short Rep (2012) 0.79
Venous thromboembolism in the cancer population: pathology, risk, and prevention. J Adv Pract Oncol (2012) 0.79
Venous thromboembolism in urologic surgery: prophylaxis, diagnosis, and treatment. Rev Urol (2010) 0.79
Rate of venous thromboembolism among surgical patients in Australian hospitals: a multicentre retrospective cohort study. BMJ Open (2014) 0.79
Non-vitamin K antagonist oral anticoagulants and the treatment of venous thromboembolism in cancer patients: a semi systematic review and meta-analysis of safety and efficacy outcomes. PLoS One (2014) 0.79
Deep Vein Thrombosis among Intensive Care Unit Patients; an Epidemiologic Study. Emerg (Tehran) (2017) 0.78
Pulmonary thromboembolism presenting with abdominal symptoms. Am J Case Rep (2012) 0.78
Primary prevention of venous thromboembolism in elderly medical patients. Clin Interv Aging (2008) 0.78
Impact of venous thromboembolism on mortality of elderly Medicare patients with stage III colon cancer. Oncologist (2012) 0.78
Risk factors for incident venous thromboembolism in active cancer patients: A population based case-control study. Thromb Res (2016) 0.77
Primary prevention and treatment of venous thromboembolic events in patients with gastrointestinal cancers - Review. World J Gastrointest Oncol (2016) 0.77
Characteristics and Risk Factors of Cancer Associated Venous Thromboembolism. Thromb Res (2015) 0.77
Heparin based prophylaxis to prevent venous thromboembolic events and death in patients with cancer - a subgroup analysis of CERTIFY. BMC Cancer (2011) 0.77
Guidelines for deep venous thrombosis prophylaxis during laparoscopic surgery. Surg Endosc (2007) 0.77
Educational outreach visits to improve venous thromboembolism prevention in hospitalised medical patients: a prospective before-and-after intervention study. BMC Health Serv Res (2013) 0.76
Management of venous thromboembolism in patients with advanced gastrointestinal cancers: what is the role of novel oral anticoagulants? Thrombosis (2012) 0.76
Physical activity and risk of venous thromboembolism. The Tromso study. Haematologica (2010) 0.76
Declining Long-term Risk of Adverse Events after First-time Community-presenting Venous Thromboembolism: The Population-based Worcester VTE Study (1999 to 2009). Thromb Res (2015) 0.75
Venous thromboembolism and cancer risk. J Thromb Thrombolysis (2017) 0.75
Direct Medical Costs Attributable to Cancer-Associated Venous Thromboembolism: A Population-Based Longitudinal Study. Am J Med (2016) 0.75
Prevention and treatment of venous thromboembolism in patients with cancer. Ther Adv Hematol (2012) 0.75
Assessments of the associations of thrombus localization with accompanying disorders, risk factors, D-dimer levels, and the red cell distribution width in pulmonary embolism. Clinics (Sao Paulo) (2015) 0.75
Incidence of venous thromboembolism in care homes: a prospective cohort study. Br J Gen Pract (2017) 0.75
IT-CARES: an interactive tool for case-crossover analyses of electronic medical records for patient safety. J Am Med Inform Assoc (2016) 0.75
Patient with a massive idiopathic thrombosis in the inferior vena cava. Ann Vasc Dis (2012) 0.75
Method of Breast Reconstruction Determines Venous Thromboembolism Risk Better Than Current Prediction Models. Plast Reconstr Surg Glob Open (2015) 0.75
[Venous thromboembolic disease in the region of Sidi Bel Abbes, Algeria: frequency and risk factors]. Pan Afr Med J (2013) 0.75
Pulmonary tuberculosis - An emerging risk factor for venous thromboembolism: A case series and review of literature. Lung India (2017) 0.75
Pattern of Venous Thrombosis in Cancer Patients: Frequency and Survival Effect; Single Center Experience. Indian J Hematol Blood Transfus (2015) 0.75
Incidences and variations of hospital acquired venous thromboembolism in Australian hospitals: a population-based study. BMC Health Serv Res (2016) 0.75
Multiple Venous Thromboses Presenting as Mechanical Low Back Pain in an 18-Year-Old Woman. J Chiropr Med (2015) 0.75
The application of clinical variables and models to predict pulmonary embolism in cancer patients: a comprehensive single cancer center experience. Patient Prefer Adherence (2013) 0.75
Testing for thrombophilia: clinical update. Br J Gen Pract (2014) 0.75
Reducing computed tomography radiation dose in diagnosing pulmonary embolism. Pak J Med Sci (2017) 0.75
Recurrent hospitalization and healthcare resource use among patients with deep vein thrombosis and pulmonary embolism: findings from a multi-payer analysis. J Thromb Thrombolysis (2015) 0.75
Epidemiology and outcomes of osteoporotic fractures. Lancet (2002) 13.09
A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med (2002) 8.63
Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up. Cancer Res (2006) 8.21
Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project. Am J Epidemiol (2011) 8.00
DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med (2006) 7.90
Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med (2006) 7.24
Benign breast disease and the risk of breast cancer. N Engl J Med (2005) 6.84
History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population. Mayo Clin Proc (2012) 6.54
Predictive value of BMD for hip and other fractures. J Bone Miner Res (2005) 6.46
Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev (2002) 6.38
Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project. Mayo Clin Proc (2012) 6.21
Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med (2005) 5.94
Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol (2008) 5.30
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target. Proc Natl Acad Sci U S A (2004) 5.13
Age-related lobular involution and risk of breast cancer. J Natl Cancer Inst (2006) 5.12
Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study. Lancet (2010) 4.75
Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum (2002) 4.69
Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance. Blood (2005) 4.48
Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system. Int J Epidemiol (2012) 4.47
Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study. J Am Coll Cardiol (2005) 4.39
Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. Arthritis Rheum (2002) 4.23
Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy. J Urol (2004) 3.92
Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm Bowel Dis (2007) 3.83
Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol (2006) 3.81
The Enterprise Data Trust at Mayo Clinic: a semantically integrated warehouse of biomedical data. J Am Med Inform Assoc (2010) 3.81
Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology (2009) 3.73
Every minute counts when the renal hilum is clamped during partial nephrectomy. Eur Urol (2010) 3.71
A reference standard for the description of osteoporosis. Bone (2007) 3.67
Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol (2003) 3.66
Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma. J Clin Oncol (2007) 3.50
Solid renal tumors: an analysis of pathological features related to tumor size. J Urol (2003) 3.48
Predictors of infection in rheumatoid arthritis. Arthritis Rheum (2002) 3.47
Natural history of asymptomatic mitral valve prolapse in the community. Circulation (2002) 3.40
Why patients visit their doctors: assessing the most prevalent conditions in a defined American population. Mayo Clin Proc (2013) 3.40
Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Arthritis Rheum (2003) 3.35
Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer (2003) 3.33
PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma. Clin Cancer Res (2007) 3.23
Trends in the mortality burden associated with diabetes mellitus: a population-based study in Rochester, Minn, 1970-1994. Arch Intern Med (2003) 3.13
Psychosocial factors are linked to functional gastrointestinal disorders: a population based nested case-control study. Am J Gastroenterol (2004) 3.11
Effects of sex and age on bone microstructure at the ultradistal radius: a population-based noninvasive in vivo assessment. J Bone Miner Res (2005) 3.11
Mortality, disability, and nursing home use for persons with and without hip fracture: a population-based study. J Am Geriatr Soc (2002) 3.09
Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma. J Urol (2010) 3.06
Diabetes mellitus and hypertension associated with shock wave lithotripsy of renal and proximal ureteral stones at 19 years of followup. J Urol (2006) 3.05
Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana. Mayo Clin Proc (2007) 2.91
Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology (2003) 2.89
Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma. Blood (2007) 2.87
Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota. Gastroenterology (2006) 2.87
Incidence of childhood distal forearm fractures over 30 years: a population-based study. JAMA (2003) 2.81
Epidemiology of gout: is the incidence rising? J Rheumatol (2002) 2.80
A population-based assessment of rates of bone loss at multiple skeletal sites: evidence for substantial trabecular bone loss in young adult women and men. J Bone Miner Res (2008) 2.76
Long-term follow-up of IgM monoclonal gammopathy of undetermined significance. Blood (2003) 2.68
Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes. Arthritis Rheum (2003) 2.64
Prevalence and burden of fecal incontinence: a population-based study in women. Gastroenterology (2005) 2.64
Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men. JAMA (2007) 2.62
Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome. Am J Surg Pathol (2004) 2.61
Serum aminotransferase activity and mortality risk in a United States community. Hepatology (2008) 2.61
A prospective, controlled assessment of factors influencing acceptance of screening colonoscopy. Am J Gastroenterol (2002) 2.60
Stratification of breast cancer risk in women with atypia: a Mayo cohort study. J Clin Oncol (2007) 2.58
Acute aortic dissection: population-based incidence compared with degenerative aortic aneurysm rupture. Mayo Clin Proc (2004) 2.55
Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors. Eur Urol (2012) 2.52
Trends in the identification and clinical features of celiac disease in a North American community, 1950-2001. Clin Gastroenterol Hepatol (2003) 2.47
Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25 years later. Mayo Clin Proc (2004) 2.43
Atypical protein kinase C iota is an oncogene in human non-small cell lung cancer. Cancer Res (2005) 2.42
Prevalence and trends in low femur bone density among older US adults: NHANES 2005-2006 compared with NHANES III. J Bone Miner Res (2010) 2.40
The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses. Eur Urol (2008) 2.40
Comparison of warm ischemia versus no ischemia during partial nephrectomy on a solitary kidney. Eur Urol (2010) 2.38
The impact of ischemia time during open nephron sparing surgery on solitary kidneys: a multi-institutional study. J Urol (2007) 2.36
The prevalence and pattern of complementary and alternative medicine use in individuals with diabetes. Diabetes Care (2002) 2.35
For estimating creatinine clearance measuring muscle mass gives better results than those based on demographics. Kidney Int (2009) 2.32
Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period. Arthritis Rheum (2004) 2.32
Incidence of multiple myeloma in Olmsted County, Minnesota: Trend over 6 decades. Cancer (2004) 2.31
B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival. Proc Natl Acad Sci U S A (2006) 2.24
Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol (2009) 2.22
Long-term survival of patients with anorexia nervosa: a population-based study in Rochester, Minn. Mayo Clin Proc (2003) 2.21
Silent pain sufferers. Mayo Clin Proc (2006) 2.20
The prevalence of atrial fibrillation in incident stroke cases and matched population controls in Rochester, Minnesota: changes over three decades. J Am Coll Cardiol (2003) 2.19
B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy. Cancer Res (2007) 2.19
Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease. J Bone Miner Res (2005) 2.15
Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study. Gastroenterology (2007) 2.14
Complications of contemporary open nephron sparing surgery: a single institution experience. J Urol (2005) 2.10
Prognostic markers of radiographic progression in early rheumatoid arthritis. Arthritis Rheum (2004) 2.08
Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. Am J Surg Pathol (2004) 2.08
Use of cost-effectiveness analysis to evaluate new technologies in orthopaedics. The case of alternative bearing surfaces in total hip arthroplasty. J Bone Joint Surg Am (2006) 2.07
Partial versus radical nephrectomy for 4 to 7 cm renal cortical tumors. J Urol (2009) 2.05
Age-dependence of femoral strength in white women and men. J Bone Miner Res (2010) 2.03
Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rheumatol (2002) 2.01
Development and evaluation of BioScore: a biomarker panel to enhance prognostic algorithms for clear cell renal cell carcinoma. Cancer (2009) 2.00
The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus. BJU Int (2004) 2.00
Relation of age, gender, and bone mass to circulating sclerostin levels in women and men. J Bone Miner Res (2011) 2.00
Immunoglobulin free light chains and solitary plasmacytoma of bone. Blood (2006) 1.98
The epidemiology of microscopic colitis: a population based study in Olmsted County, Minnesota. Gut (2006) 1.97
Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma. Clin Cancer Res (2008) 1.97
The unitary model for estrogen deficiency and the pathogenesis of osteoporosis: is a revision needed? J Bone Miner Res (2011) 1.95
Small bowel obstruction-who needs an operation? A multivariate prediction model. World J Surg (2010) 1.94
Modeling chronic glycemic exposure variables as correlates and predictors of microvascular complications of diabetes. Diabetes Care (2006) 1.93
Outcome of stage T2 or greater renal cell cancer treated with partial nephrectomy. J Urol (2010) 1.93
Long-term risk of depressive and anxiety symptoms after early bilateral oophorectomy. Menopause (2008) 1.92
Increasing incidence of melanoma among young adults: an epidemiological study in Olmsted County, Minnesota. Mayo Clin Proc (2012) 1.92